Multiple Study of Electroaccpuncture in ARDS
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNanjing University of Traditional Chinese Medicine
About this trial
In order to clarify the clinical efficacy of electroacupuncture on inhibiting systemic inflammatory response, improving respiratory mechanics parameters and prognosis in patients with sepsis-related ARDS.
Eligibility criteria
Qualifiers
Meet the diagnostic criteria of the Surviving Sepsis Campaign: Updated International Guidelines for the Treatment of Sepsis and Septic Shock 2021
Meet the diagnostic criteria of the European Society of Critical Care Medicine (ESICM) Guidelines for Acute Respiratory Distress Syndrome: Definition, Phenotype and Respiratory Support Strategies
Age >18 years
Expected duration of mechanical ventilation>48 hours
Disqualifiers
Participated in other clinical trials
Pregnant, lactating or miscarriage
Patients with disseminated tumors or tumors receiving chemotherapy and other special treatments
Alcohol abuse
Trial design
Treatments tested in this trial
- Acupuncture needles
Treatment groups
264 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov